Clinical Trial Update: VNP40101M in Treating Patients With Advanced Solid Tumors or Lymphomas [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase 1 study of VNP40101M in patients with advanced solid tumors or lymphomas.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Small Intestine Cancer

Drugs mentioned

• VNP40101M

Snippet

Sponsor: Vion Pharmaceuticals | Conditions: Lymphoma, Small Intestine Cancer | Phase 1 | Status: COMPLETED